Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (6): 1065-1067. doi: 10.19723/j.issn.1671-167X.2022.06.001
适 陈*(
),田 刘
CLC Number:
- R593.2
| 1 |
Kitching AR , Anders HJ , Basu N , et al. ANCA-associated vasculitis[J]. Nat Rev Dis Primers, 2020, 6 (1): 71.
doi: 10.1038/s41572-020-0204-y |
| 2 | Aladdin JM . An update on the epidemiology of ANCA-associated vasculitis[J]. Rheumatology (Oxford), 2020, 59 (Suppl 3): 42- 50. |
| 3 | Gary SF , Ralph CB , Sherine EG , et al. Kelley & Firestein's textbook of rheumatology[M]. 11th. Philadelphia: Elsevier, 2020: 1485. |
| 4 | 余洁, 陈适, 栗占国. 抗中性粒细胞胞浆抗体阳性患者疾病谱分析[J]. 中华全科医师杂志, 2010, 9 (1): 26- 30. |
| 5 |
赵明辉. 抗中性粒细胞胞质抗体相关小血管炎诊断和治疗中的问题与对策[J]. 中华风湿病学杂志, 2009, 13 (4): 217- 219.
doi: 10.3760/cma.j.issn.1007-7480.2009.04.001 |
| 6 |
Buttgereit F , Dejaco C , Matteson EL , et al. Polymyalgia rheumatica and giant cell arteritis: A systematic review[J]. JAMA, 2016, 315 (22): 2442- 2458.
doi: 10.1001/jama.2016.5444 |
| 7 | Yanaoka H , Nagafuchi Y , Hanata N , et al. Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls[J]. J Autoimmun, 2021, 119 (5): 102617. |
| 8 |
Chen Z , Zhao YY , Wang Q , et al. Imaging features of 18FFDG PET/CT in different types of systemic vasculitis[J]. Clin Rheumatol, 2022, 41 (5): 1499- 1509.
doi: 10.1007/s10067-021-06039-1 |
| 9 |
Robson JC , Grayson PC , Ponte C , et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis[J]. Ann Rheum Dis, 2022, 81 (3): 315- 320.
doi: 10.1136/annrheumdis-2021-221795 |
| 10 | Suppiah R , Robson JC , Grayson PC , et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis[J]. ArthritisRheumatol, 2022, 74 (3): 400- 406. |
| 11 |
Jones RB , Tervaert JW , Hauser T , et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis[J]. N Engl J Med, 2010, 363 (3): 211- 220.
doi: 10.1056/NEJMoa0909169 |
| 12 |
Michael W , Peter AM , Chen AP , et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis[J]. N Engl J Med, 2020, 382 (7): 622- 631.
doi: 10.1056/NEJMoa1803537 |
| 13 |
de Groot K , Rasmussen N , Bacon PA , et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis[J]. Arthritis Rheum, 2005, 52 (8): 2461- 2469.
doi: 10.1002/art.21142 |
| 14 |
Guillevin L , Pagnoux C , Karras A , et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis[J]. N Engl J Med, 2014, 371 (19): 1771- 1780.
doi: 10.1056/NEJMoa1404231 |
| 15 |
Pagnoux C , Mahr A , Hamidou MA , et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis[J]. N Engl J Med, 2008, 359 (26): 2790- 2803.
doi: 10.1056/NEJMoa0802311 |
| 16 | Goglin S , Chung SA . New developments in treatments for systemic vasculitis[J]. Curr Opin Pharmacol, 2022, 66 (10): 102270. |
| 17 |
Sharon AC , Carol AL , Mehrdad M , et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis[J]. Arthritis Care Res(Hoboken), 2021, 73 (8): 1088- 1105.
doi: 10.1002/acr.24634 |
| 18 |
Michael EW , Praveen A , David J , et al. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis[J]. N Engl J Med, 2017, 376 (20): 1921- 1932.
doi: 10.1056/NEJMoa1702079 |
| 19 | David RJ , Peter AM , Thomas JS , et al. Avacopan for the treatment of ANCA-associated vasculitis[J]. N Engl J Med, 2021, 384 (7): 599- 609. |
| 20 | Maz M , Chung SA , Abril A , et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the management of giant cell arteritis and Takayasu arteritis[J]. Arthritis Rheumatol, 2021, 73 (8): 1349- 1365. |
| 21 | He J , Zhang R , Shao M , et al. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: A randomised, double-blind, placebo-controlled trial[J]. Ann Rheum Dis, 2020, 79 (1): 141- 149. |
| 22 | Michelle R , Roberta L , Patrice C , et al. Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial[J]. Ann Rheum Dis, 2019, 78 (2): 209- 217. |
| 23 | Carol AL , David C , Steven RY , et al. A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of giant cell arteritis[J]. Arthritis Rheumatol, 2017, 69 (4): 837- 845. |
| 24 | Nils V , Wolfgang AS , Peter L , et al. Efficacy and safety of secukinumab in patients with giant cell arteritis: Study protocol for a randomized, parallel group, double-blind, placebo-controlled phase Ⅱ trial[J]. Trials, 2021, 22 (1): 543. |
| 25 | Kong XF , Sun Y , Dai XJ , et al. Treatment efficacy and safety of tofacitinib versus methotrexate in Takayasu arteritis: A prospective observational study[J]. Ann Rheum Dis, 2022, 81 (1): 117- 123. |
| [1] | Fang CHENG,Shao-ying YANG,Xing-xing FANG,Xuan WANG,Fu-tao ZHAO. Role of the CCL28-CCR10 pathway in monocyte migration in rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1074-1078. |
| [2] | Jing-feng ZHANG,Yin-ji JIN,Hui WEI,Zhong-qiang YAO,Jin-xia ZHAO. Cross-sectional study on quality of life and disease activity of rheumatoid arthritis patients [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1086-1093. |
| [3] | Lu ZHANG,Cheng CHEN,Mei-ting WENG,Ai-ping ZHENG,Mei-ling SU,Qing-wen WANG,Yue-ming CAI. Characteristics of serum autoantibodies in patients with lupus nephritis and tubulointerstitial damage [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1094-1098. |
| [4] | Lin-qi ZHANG,Jing ZHAO,Hong-yan WANG,Zong-yi WANG,Ying-ni LI,Ji-yang TANG,Si-ying LI,Jin-feng QU,Ming-wei ZHAO. Relationship between anti-ENO1 antibody and systemic lupus erythematosus patients with retinopathy [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1099-1105. |
| [5] | Miao SHAO,Hui-fang GUO,Ling-yan LEI,Qing ZHAO,Yan-jie DING,Jin LIN,Rui WU,Feng YU,Yu-cui LI,Hua-li MIAO,Li-yun ZHANG,Yan DU,Rui-ying JIAO,Li-xia PANG,Li LONG,Zhan-guo LI,Ru LI. A multicenter study on the tolerance of intravenous low-dose cyclophosphamide in systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1112-1116. |
| [6] | Yang LIU,Fang CHENG,Yan-ling WANG,Xiang-yan AI,Zhen-hang ZHU,Fu-tao ZHAO. Diagnostic performances of salivary gland ultrasonography for Sjögren's syndrome [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1123-1127. |
| [7] | Rui-jie CAO,Zhong-qiang YAO,Peng-qing JIAO,Li-gang CUI. Comparison of diagnostic efficacy of different classification criteria for Takayasu arteritis in Chinese patients [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1128-1133. |
| [8] | Xiao-yan XING,Jun-xiao ZHANG,Feng-yun-zhi ZHU,Yi-fan WANG,Xin-yao ZHOU,Yu-hui LI. Clinical analysis of 5 cases of dermatomyositis complicated with macrophage activation syndrome [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1214-1218. |
| [9] | 靓 罗,青猛 蔡,香君 刘,泽霖 贠,春 李,晓盈 张. [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1224-1228. |
| [10] | 红霞 李,雅馨 周,亚飞 王,鹏宇 王,振彪 吴. [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1229-1233. |
| [11] | Wen-xin CAI,Shi-cheng LI,Yi-ming LIU,Ru-yu LIANG,Jing LI,Jian-ping GUO,Fan-lei HU,Xiao-lin SUN,Chun LI,Xu LIU,Hua YE,Li-zong DENG,Ru LI,Zhan-guo LI. A cross-sectional study on the clinical phenotypes of rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1068-1073. |
| [12] | Rui LIU,Jin-xia ZHAO,Liang YAN. Clinical characteristics of patients with rheumatoid arthritis complicated with venous thrombosis of lower extremities [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1079-1085. |
| [13] | Min LI,Lin-qing HOU,Yue-bo JIN,Jing HE. Clinical and immunological characteristics of systemic lupus erythematosus with retinopathy [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1106-1111. |
| [14] | Yu-ke HOU,Qing-meng CAI,Xiang-jun LIU,Ze-lin YUN,Chun LI,Xue-wu ZHANG. Clinical significance of oxidized low-density lipoprotein antibody in antiphospholipid syndrome [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1117-1122. |
| [15] | 朝焰 徐,长艺 林,达梅 叶,培埕 吴,明辉 宋,有添 刘,琼 邓,雪艳 黄,忠晓 范,雪兰 游. [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1234-1237. |